|
Valoración de DCF de Equillium, Inc. (EQ)
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Equillium, Inc. (EQ) Bundle
¡Simplifique la valoración de Equillium, Inc. (EQ) con esta calculadora DCF personalizable! Con Real Equillium, Inc. (EQ) financieros y entradas de pronóstico ajustables, puede probar escenarios y descubrir el valor razonable de Equillium, Inc. (EQ) en minutos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | 15.8 | 36.1 | 45.1 | 56.4 | 70.5 | 88.1 | 110.1 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 128.97 | 25 | 25 | 25 | 25 | 25 |
| EBITDA | -25.3 | -28.7 | -37.9 | -61.3 | -12.1 | 15.0 | 18.8 | 23.4 | 29.3 | 36.6 |
| EBITDA, % | 100 | 100 | 100 | -388.71 | -33.64 | 33.27 | 33.27 | 33.27 | 33.27 | 33.27 |
| Depreciation | .0 | .0 | .1 | .1 | .1 | 27.2 | 34.0 | 42.4 | 53.1 | 66.3 |
| Depreciation, % | 100 | 100 | 100 | 0.74878 | 0.34919 | 60.22 | 60.22 | 60.22 | 60.22 | 60.22 |
| EBIT | -25.3 | -28.7 | -38.0 | -61.4 | -12.3 | 15.0 | 18.7 | 23.4 | 29.2 | 36.6 |
| EBIT, % | 100 | 100 | 100 | -389.46 | -33.99 | 33.2 | 33.2 | 33.2 | 33.2 | 33.2 |
| Total Cash | 53.1 | 82.2 | 80.7 | 71.0 | 40.9 | 45.1 | 56.4 | 70.5 | 88.1 | 110.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | 2.8 | 6.3 | 30.3 | 37.8 | 47.3 | 59.1 | 73.9 |
| Account Receivables, % | 100 | 100 | 100 | 18.01 | 17.42 | 67.09 | 67.09 | 67.09 | 67.09 | 67.09 |
| Inventories | .0 | .0 | .0 | .0 | .0 | 27.1 | 33.8 | 42.3 | 52.9 | 66.1 |
| Inventories, % | 100 | 100 | 100 | 0 | 0 | 60 | 60 | 60 | 60 | 60 |
| Accounts Payable | 1.9 | 2.8 | 1.2 | 4.0 | 4.7 | 30.5 | 38.1 | 47.7 | 59.6 | 74.5 |
| Accounts Payable, % | 100 | 100 | 100 | 25.24 | 13.04 | 67.66 | 67.66 | 67.66 | 67.66 | 67.66 |
| Capital Expenditure | -.1 | -.2 | -.1 | -.3 | -.1 | -.2 | -.2 | -.3 | -.3 | -.4 |
| Capital Expenditure, % | 100 | 100 | 100 | -1.77 | -0.13857 | -0.3818 | -0.3818 | -0.3818 | -0.3818 | -0.3818 |
| Tax Rate, % | -4.55 | -4.55 | -4.55 | -4.55 | -4.55 | -4.55 | -4.55 | -4.55 | -4.55 | -4.55 |
| EBITAT | -25.3 | -28.7 | -37.9 | -105.9 | -12.8 | 15.0 | 18.7 | 23.4 | 29.2 | 36.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -23.5 | -27.9 | -39.4 | -106.1 | -15.5 | 16.7 | 45.7 | 57.2 | 71.5 | 89.3 |
| WACC, % | 14.6 | 14.6 | 14.6 | 14.61 | 14.61 | 14.6 | 14.6 | 14.6 | 14.6 | 14.6 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 174.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 91 | |||||||||
| Terminal Value | 723 | |||||||||
| Present Terminal Value | 366 | |||||||||
| Enterprise Value | 540 | |||||||||
| Net Debt | -22 | |||||||||
| Equity Value | 562 | |||||||||
| Diluted Shares Outstanding, MM | 35 | |||||||||
| Equity Value Per Share | 16.19 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real EQ financials.
- Real-World Data: Historical data and forward-looking estimates (as highlighted in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effects of your inputs on Equillium’s valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Comprehensive Equillium Financials: Gain access to precise historical data and future forecasts tailored for Equillium, Inc. (EQ).
- Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic recalculations of DCF, Net Present Value (NPV), and cash flow metrics.
- Interactive Dashboard: User-friendly charts and summaries to help you visualize valuation outcomes effectively.
- Designed for All Skill Levels: An intuitive layout catering to investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review Equillium, Inc.'s (EQ) pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Choose This Calculator for Equillium, Inc. (EQ)?
- All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for Equillium, Inc. (EQ).
- Flexible Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes Equillium, Inc.'s (EQ) intrinsic value and Net Present Value.
- Integrated Data: Access historical and projected data for a solid foundation in your analysis.
- Expert-Level Tool: Designed for financial analysts, investors, and business advisors focused on Equillium, Inc. (EQ).
Who Should Use This Product?
- Investors: Effectively assess Equillium, Inc.'s (EQ) fair value prior to making investment choices.
- CFOs: Utilize a robust DCF model for accurate financial reporting and analysis for Equillium, Inc. (EQ).
- Consultants: Seamlessly modify the template for client valuation reports related to Equillium, Inc. (EQ).
- Entrepreneurs: Acquire knowledge about the financial modeling practices of leading biotech firms like Equillium, Inc. (EQ).
- Educators: Implement it as a resource to illustrate valuation techniques in finance courses.
What the Template Contains
- Pre-Filled Data: Includes Equillium, Inc.'s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Equillium, Inc.'s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.